A
AAPG
Ascentage Pharma Group International American Depository Shares
$14.85
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Ascentage Pharma Group International American Depository Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$3.95
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Posts
No posts about AAPG yet.
About Ascentage Pharma Group International American Depository Shares
Ascentage Pharma is a China-based biotechnology company that develops cancer drugs. These are mostly targeted pills meant to help the body's own cell-death process kill cancer cells. It has no big product line yet, so it earns modest revenue from approved drugs and partnerships while it spends heavily on research and trials. Its shares trade in the US as American Depository Shares, which are certificates that represent shares of the foreign company.